In DMD, miRNAs may be useful for several therapeutic strategies, such as for the stimulation of dystrophin or utrophin synthesis, the reduction of fibrosis, and the improvement of cardiac abnormalities. This evidence concerns the gene DMD and Duchenne muscular dystrophy.